| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $121.19 | $23.81 | 409.07% | 228.66x | 57.68x | 15.37x | 18.56x | 1.66x | $106.92M | 0.84% | $705.78M | 6.70 | $13.00B | 1,656.96 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.22 | $8.13 | 222.39% | 124.86x | 58.62x | 7.38x | 14.94x | 1.07x | $39.15M | 1.14% | $220.58M | 1.69 | $3.38B | 74.36 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $227.02 | $79.68 | 184.90% | 37.22x | 33.67x | 6.31x | 22.43x | 1.28x | $793.95M | 2.62% | $1.35B | 10.14 | $31.66B | 26.84 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.24 | $17.15 | 362.01% | 74.06x | 67.79x | 7.31x | 9.45x | 1.89x | $182.84M | 2.97% | $654.15M | 8.43 | $6.02B | 50.15 | ||
| RPRX | ROYALTY PHARMA PLC | $57.78 | $35.83 | 61.27% | 30.73x | 10.56x | 10.14x | 3.40x | 0.62x | $2.92B | 11.37% | $9.79B | 21.99 | $41.37B | 35.18 | ||
| VCEL | VERICEL CORP | $40.62 | $7.92 | 413.07% | 84.63x | 72.57x | 6.77x | 5.62x | 2.08x | $61.66M | 2.97% | $370.04M | 7.25 | $2.05B | 46.48 | ||
| KRYS | KRYSTAL BIOTECH INC | $332.07 | $83.15 | 299.39% | 40.15x | 42.54x | 22.26x | 7.23x | 2.15x | $257.78M | 2.63% | $1.36B | 46.03 | $9.41B | 40.34 | ||
| HALO | HALOZYME THERAPEUTICS INC | $111.08 | $70.47 | 57.64% | 31.20x | 12.30x | 7.83x | 87.83x | 0.60x | $806.22M | 6.19% | $143.54M | 1.22 | $14.59B | 20.31 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.39 | $18.45 | 200.16% | 145.76x | 19.14x | 3.15x | 1.70x | 0.97x | $738.18M | 6.89% | $6.32B | 32.68 | $14.03B | 36.39 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.32 | $7.54 | 50.19% | 11.92x | 10.40x | 4.92x | 3.09x | 1.04x | $82.01M | 12.24% | $217.65M | 3.68 | $528.40M | 6.83 | ||
| TGTX | TG THERAPEUTICS INC | $55.27 | $22.20 | 148.95% | 17.94x | 55.61x | 9.80x | 14.00x | 2.00x | $17.39M | 0.22% | $604.08M | 4.26 | $8.73B | 62.70 | ||
| ADMA | ADMA BIOLOGICS INC | $10.18 | $6.91 | 47.32% | 14.14x | 12.80x | 4.53x | 5.59x | 0.82x | $116.47M | 5.01% | $408.21M | 1.79 | $2.34B | 10.05 | ||
| EXEL | EXELIXIS INC | $59.82 | $29.71 | 101.32% | 18.18x | 18.08x | 6.16x | 8.04x | 1.19x | $1.17B | 7.82% | $1.84B | 7.35 | $14.71B | 13.52 | ||
| MDXG | MIMEDX GROUP INC | $4.83 | $1.26 | 283.10% | 120.75x | -27.85x | 2.01x | 3.26x | 1.31x | $44.50M | 6.23% | $216.00M | 1.46 | $585.39M | 25.66 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $216.75 | $178.52 | 21.42% | 14.20x | 8.48x | 2.98x | 2.93x | 0.58x | $1.62B | 11.82% | $4.80B | 75.98 | $16.85B | 10.42 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $311.13 | $85.02 | 265.96% | 30.90x | 32.93x | 21.49x | 6.41x | 2.34x | $130.62M | 2.09% | $967.52M | 48.22 | $6.33B | 22.68 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $507.00 | $146.93 | 245.07% | 29.26x | 26.48x | 10.22x | 6.35x | 2.20x | $3.80B | 2.95% | $20.25B | 79.81 | $124.34B | 22.59 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.23 | $29.80 | 28.28% | 12.18x | 9.17x | 2.31x | 2.23x | 0.73x | $354.90M | 16.02% | $999.24M | 17.25 | $1.83B | 6.54 | ||
| UTHR | UNITED THERAPEUTICS CORP | $550.10 | $186.79 | 194.50% | 18.19x | 20.59x | 7.43x | 3.69x | 3.34x | $1.09B | 4.66% | $6.40B | 150.24 | $21.79B | 13.00 | ||
| TECH | BIO-TECHNE CORP | $72.56 | $16.13 | 349.97% | 62.02x | 34.92x | 9.31x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.80 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $762.81 | $423.76 | 80.01% | 18.19x | 13.60x | 5.05x | 2.48x | 0.96x | $3.76B | 4.80% | $31.71B | 308.48 | $78.79B | 13.70 | ||
| VCYT | VERACYTE INC | $44.02 | $11.61 | 279.03% | 30.57x | 22.63x | 6.27x | 2.55x | 2.57x | $165.99M | 4.72% | $1.39B | 17.36 | $3.28B | 23.47 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.18 | $1.37 | -14.16% | 8.43x | -2.66x | 1.45x | 1.55x | 0.47x | $19.58M | 28.64% | $44.20M | 0.76 | $19.99M | 2.61 | ||
| INCY | INCYTE CORP | $111.36 | $58.34 | 90.89% | 13.71x | 31.41x | 3.83x | 3.56x | 1.54x | $1.92B | 8.61% | $6.34B | 31.66 | $18.62B | 9.00 |